Table 1.
Clinical Outcome |
Overall | Death | PD --> HD | Transplant | Maintain PD | p-value | |
---|---|---|---|---|---|---|---|
N = 100 | N = 12 | N = 12 | N = 10 | N = 66 | |||
Total follow-up time (days) mean (SD) |
300 (112) | 172 (100) | 192 (139) | 161 (112) | 363 (16) | ||
Baseline Demographics | |||||||
Age (yrs): mean (SD) | 51.8 (17.0) | 56.3 (15.9) | 51.3 (14.6) | 39.2 (14.2) | 53.0 (17.3) | 0.080 | |
Gender (male) | 57 (57.0%) | 9 (75.0%) | 7 (58.3%) | 5 (50.0%) | 36 (54.5%) | 0.594 | |
Race (%) | 0.868 | ||||||
African American | 31 (31.0%) | 4 (33.3%) | 5 (41.7%) | 4 (40.0%) | 18 (27.3%) | ||
Hispanic | 4 (4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 4 (6.1%) | ||
Southeast Asian | 1 (1%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (1.5%) | ||
White American | 64 (64.0%) | 8 (66.7%) | 7 (58.3%) | 6 (60.0%) | 43 (65.2%) | ||
90-day Incident (%) | 23 (23.0%) | 1 (8.3%) | 4 (33.3%) | 1 (10.0%) | 17 (25.8%) | 0.363 | |
Prevalent (%) | 77 (77.0%) | 11 (91.7%) | 8 (66.7%) | 9 (90.0%) | 49 (74.2%) | ||
Vintage (days): mean (SD) | 571 (584) | 900 (799) | 474 (692) | 537 (371) | 553 (537) | 0.218 | |
Baseline Comorbid Conditions | |||||||
Diabetes mellitus (%) | 46(46.0%) | 8 (66.7%) | 5 (41.7%) | 1 (10.0%) | 32(48.5%) | 0.062 | |
Hypertension (%) | 85 (85.0%) | 9 (75.0%) | 9 (75.0%) | 9 (90.0%) | 58 (87.9%) | 0.516 | |
Cardiac disease (%) | 32 (32.0%) | 8 (66.7%) | 2 (16.7%) | 0 (0.0%) | 22 (33.3%) | 0.004 | |
Malignancy (%) | 19 (19.0%) | 1 (8.3%) | 3 (25.0%) | 3 (30.0%) | 12 (18.2%)) | 0.578 | |
Depression/Anxiety (%) | 37 (37%) | 5 (41.7%) | 3 (25%) | 3 (30%) | 26 (39.4%) | 0.762 | |
Albumin: mean (SD) | 3.5 (0.49) | 3.0 (0.48) | 3.3 (0.44) | 3.6 (0.42) | 3.6 (0.45) | < .001 | |
Davies Comorbidity Score | 1.19 (1.07) | 1.92 (1.24) | 1.00 (0.85) | 0.40 (0.52) | 1.21 (1.06) | 0.008 | |
Psychosocial Measurements | |||||||
Mindset Scale: mean (SD) | 12.77 (4.2) | 10 (5.2) | 13 (4.2) | 15 (2.1) | 12.89 (4.1) | 0.042 | |
Health Literacy: mean (SD) | 12.54 (2.7) | 11.08 (3.3) | 13.58 (2.9) | 12.70 (1.8) | 12.59 (2.7) | 0.159 | |
Health Self-Efficacy (SD) | 13.3 (3.3) | 11.6 (3.1) | 13.6 (3.8) | 13.9 (2.4) | 13.4 (3.3) | 0.300 |